Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 08, 2012
Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract development and manufacturing organization (CDMO), has announced the appointment of John K. Lynch, Ph.D. as its Chief Scientific Officer (CSO).
read more
Recently. FDA issued the DSCSA Implementation: Product Tracing Requirements for Dispensers–Compliance Policy Guidance. This document announces that FDA does not intend to take enforcement action against dispensers who, prior to November 1, 2015:
read more
Wednesday, April 01, 2026
NJ Bio and Ajinomoto Bio Pharma Services announced a research collaboration to expand access to AJICAP™, Aji Bio Pharma's site specific conjugation platform for NJ Bio's discovery stage and early development clients.
read more
Tuesday, November 13, 2018
Angion Biomedica and Sinovant Sciences announced a collaboration and license agreement for BB3, Angion's investigational small molecule mimetic of hepatocyte growth factor (HGF), China, Hong Kong, Macau, and Taiwan.
read more
Monday, December 23, 2019
Fortress Biotech announced Baergic Bio entered into an agreement with AstraZeneca for AZD7325, a novel a2/3–subtype-selective GABA A PAM, as well as an agreement with Cincinnati Children’s Hospital Medical Center to advance clinical development in ...
read more
WPD announced independent research on WP1122 drug compound found 2-DG to reduce replication of SARS-CoV-2 by 100% in in vitro testing.
read more
EUROAPI has expanded its collaboration with Sanofi under the umbrella of their Master Agreement for Development and GMP Manufacturing Services (the “DSA”), dated October 1, 2021, to support Sanofi’s mRNA vaccine platform with the development of lipid...
read more
PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global consultancy serving the biopharmaceutical and medical device industries, today announced that Leanne R. Larson has been appointed as Vice President, ...
read more
SpineThera, Inc., a clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain) and ProMed Pharma ...
read more
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
read more
Tuesday, January 06, 2015
3C! Packaging, an independent privately-owned pharmaceutical packaging solutions company specializing in the design and manufacture of custom folding cartons, printed literature, inserts/outserts, labels/foils and unit dose applications, will begin ...
read more
Solvias, a large independent analytical testing, contract research, development and manufacturing company, announced that it has acquired Canton, Mass.-based Chemic Laboratories, Inc. (Chemic). With this acquisition, Solvias gains a strong foothold ...
read more
SGS has announced that it has invested in multiple highly sensitive and selective LC-MS/MS instruments at its Poitiers, France laboratory, for the quantification of proteins and peptide therapeutics.
read more
Wednesday, December 26, 2018
GenomOncology announced today that Brad Wertz will assume the role of Chairman and Chief Executive Officer (CEO) as of January 1, 2019.
read more
Wednesday, August 14, 2019
M2Gen announced the appointment of Helge Bastian, Ph.D., as president and chief executive officer (CEO).
read more